European Journal of Organic Chemistry
10.1002/ejoc.201700105
FULL PAPER
–
1
–1
1
SiO
yield the crude product.
(4-Biphenylyl)methyl)-1H-tetrazole (2a) The crude product
2
the solvent was removed under reduced pressure to
Mp: 122.7-123.4 °C; νCH(Tz)cm : 3136, νC=O cm : 1685; H
NMR (400 MHz, CD Cl , δ): 8.68 (s, 1H, TzCH), 7.58 (ddd,
2
2
(
J = 7.6, 1.5, 0.6 Hz, 1H, ArH), 7.53 (td, J = 7.5, 1.5 Hz, 1H,
was recrystallized from DCM:PE (1:1) to afford 2a (white
solid, 95.9 mg, 97.2 % yield).
ArH), 7.44 (td, J = 7.5, 1.3 Hz, 1H, ArH), 7.39 – 7.33 (m,
); 13C{ H }
1
5H, ArH), 5.66 (s, 2H, CH
NMR (101 MHz, CD Cl
2
), 2.13 (s, 3H, CH
3
–
1
1
Mp: 178.9-179.6 °C; νCH(Tz) cm : 3113; H NMR (400 MHz,
CD Cl2, δ): 8.59 (s, 1H, Tz-CH), 7.65 (d, J = 8.6 Hz, 2H,
ArH), 7.60 (dd, J = 8.4, 1.4 Hz, 2H, ArH), 7.50 – 7.43 (m,
2
2
, δ): 203.82 (AcC), 143.22 (TzCH,
2
142.50 (ArC), 140.94 (ArC), 140.10 (ArC), 133.25 (ArC),
131.37 (ArCH), 131.02 (ArCH), 130.19 (2ArCH), 128.95
2
H, ArH), 7.42 – 7.36 (m, 3H, ArH), 5.63 (s, 2H CH
2
);
(2ArCH), 128.55 (ArCH), 128.29 (ArCH), 52.23 (CH
(CH ); HRMS (ESI-TOF) m/z: [M
Na]+ Calc. for
NaO: 301.1065, found 301.1067.
(4'-((1H-Tetrazolyl)methyl)-4-biphenylyl)ethan-1-one
2
), 30.66
1
3
1
C{ H } NMR (101 MHz, CD
2
Cl
2
, δ): 143.07 (TzCH), 142.70
3
+
(ArC), 140.56 (ArC), 132.67 (ArC), 129.46 (ArC), 129.38
2ArCH), 128.48 (2ArCH), 128.38 (ArCH), 127.61 (2ArCH),
16 14 4
C H N
(
(2f)
5
2.42 (CH
Na: 259.0960, found 259.0953.
(2'-Methyl-4-biphenylyl)methyl)-1H-tetrazole
2
); HRMS (ESI-TOF) m/z: [M + Na]+ Calc. for
The crude product was recrystallized with DCM:PE (1:1) to
afford 2f (white solid, 101.4 mg, 87.1 % yield).
14 12 4
C H N
–
1
(
(2b)
The
Mp: 134.7-136.2 °C; νCH(Tz) cm : 3106 (νTz), νC=O: 1680
1
crude product was purified by column chromatography on
silica gel with ethyl acetate/petroleum ether (1:1) to afford
(C=O); H NMR (400 MHz, CD
2
Cl
2
, δ): 8.61 (s, 1H, TzCH),
8.08 – 8.00 (m, 2H, ArH), 7.70 (dd, J = 8.6, 2.0 Hz, 4H,
2
b (clear viscous liquid, 95.3 mg, 91.0 % yield).
ArH), 7.45 – 7.39 (m, 2H, ArH), 5.65 (s, 2H, CH
2
), 2.61 (s,
–
1
1
); 13C{ H } NMR (101 MHz, CD
1
ν
CH(Tz) cm : 3130; H NMR (400 MHz, CD
2
Cl2, δ): 8.63 (s,
3H, CH
3
2
Cl2, δ): 197.85
1
5
H, TzCH), 7.37 (s, 4H, ArH), 7.31 – 7.14 (m, 4H, ArH),
(C=O), 144.89 (ArC), 143.11 (TzCH), 141.40 (ArC), 136.98
(ArC), 133.67 (ArC), 129.48 (2ArCH), 129.44 (2ArCH),
); 13C{ H } NMR (101
1
.64 (s, 2H, CH
2
), 2.24 (s, 3H, CH
3
MHz, CD
2
Cl2, δ): 143.56, 143.13, 141.38, 135.85, 132.25,
128.67 (2ArCH), 127.75 (2ArCH), 52.32 (CH
HRMS (ESI-TOF) m/z: [M + H]+ Calc. for C16
2
), 27.08 (CH
3
);
130.95, 130.64, 130.12, 128.65, 128.17, 126.39, 52.45
15 4
H N
O:
+
(
CH
2
3
), 20.69 (CH ); HRMS (ESI-TOF) m/z: [M + H] Calc.
279.1246, found 279.1247.
for C15
H
15
N
4
: 251.1297, found 251.1299.
(3'-Methyl-4-biphenylyl)methyl)-1H-tetrazole (2c) The crude
product was recrystallized with DCM:PE (1:1) to afford 2c
white solid, 101.6 mg, 97.1 % yield).
(4'-((1H-Tetrazolyl)methyl)-4-biphenylyl)carboxylic acid (2g)
The crude product was recrystallized with EA to afford 2g
(white solid, 109,0 mg, 93.8 % yield).
(
Mp: 267 °C (decomp.); νCH(Tz) cm : 3118, νC=O: 1674; 1
H
–
1
(
–
1
1
Mp: 122.2-123.6 °C; νCH(Tz) cm : 3126; H NMR (400 MHz,
CD Cl2, δ): 8.60 (s, 1H, TzCH), 7.64 (d, J = 8.3 Hz, 2H,
ArH), 7.43 – 7.41 (m, 1H, ArH), 7.41 – 7.36 (m, 3H, ArH),
NMR (400 MHz, DMSO-d6, δ): 13.00 (s, 1H, COOH), 9.57
(s, 1H, TzCH), 8.01 (d, J = 8.6 Hz, 2H, ArCH), 7.78 (dd, J =
2
11.2, 8.5 Hz, 4H, ArCH), 7.47 (d, J = 8.4 Hz, 2H, ArCH),
); 13C{ H } NMR (101 MHz, DMSO-d
1
7.33 (t, J = 7.5 Hz, 1H, ArH), 7.20 (d, J = 1.0 Hz, 1H, ArH),
5.78 (s, 2H, CH
2
6
, δ):
); 13C{ H} NMR (101
1
167.05 (C=O), 144.09 (TzCH), 143.52 (ArC), 139.12 (ArC),
134.81 (ArC), 129.94 (2ArCH), 129.86 (ArC), 128.88
5
.63 (s, 2H, CH
Cl
ArC), 139.23 (ArC), 132.56 (ArC), 129.32 (3ArCH), 129.09
ArCH), 128.43 (2ArCH), 128.33 (ArCH), 124.66 (ArCH),
2.40 (CH ), 21.77 (CH
); HRMS (ESI-TOF) m/z: [M + H]+
Calc. for C15 : 251.1297, found 251.1297.
(4'-Methyl-4-biphenylyl)methyl)-1H-tetrazole
2
), 2.41 (s, 3H, CH
3
MHz, CD
2
2
, δ): 143.09 (TzCH), 142.80 (ArC), 140.45
(
(
2
(2ArCH), 127.45 (2ArCH), 126.83 (2ArCH), 50.41 (CH );
HRMS (ESI-TOF) m/z: [M + H]+ Calc. for C15
13 4 2
H N O :
5
2
3
281.1039, found 281.1037.
H
15
N
4
((3'-Nitro-4-biphenylyl)methyl)-1H-tetrazole (2h) The crude
product was purified by column chromatography on silica
gel with EA:PE (2:1) to afford 2h (slightly yellow solid, 97.9
mg, 79.7 % yield).
(
(2d)
The
crude product was recrystallized with DCM:PE (1:1) to
afford 2d (white solid, 90 mg, 86.1 % yield).
–
1
1
–1
1
Mp: 167.0-168.3 °C; νCH(Tz) cm : 3099; H NMR (400 MHz,
CD Cl2, δ): 8.59 (s, 1H, TzCH), 7.63 (d, J = 8.3 Hz, 2H,
ArH), 7.49 (d, J = 8.3 Hz, 2H, ArH), 7.37 (d, J = 8.4 Hz, 2H,
Mp: 146.4-147.5 °C; νCH(Tz) cm : 3125; H NMR (400 MHz,
CD Cl , δ): 8.63 (s, 1H), 8.44 (t, J = 2.0 Hz, 1H, TzCH),
2
2
2
8.21 (ddd, J = 8.2, 2.3, 1.0 Hz, 1H, ArH), 7.93 (ddd, J = 7.8,
1.8, 1.0 Hz, 1H, ArH), 7.73 – 7.68 (m, 2H, ArH), 7.65 (t, J =
ArH), 7.27 (d, J = 7.9 Hz, 2H, ArH), 5.62 (s, 2H, CH
2
), 2.39
); 13C{ H } NMR (101 MHz, CD
1
Cl2, δ): 143.07
8.0 Hz, 1H, ArH), 7.49 – 7.41 (m, 2H), 5.66 (s, 2H, CH
);
(
(
(
s, 3H, CH
3
2
2
1
3
1
TzCH), 142.59 (ArC), 138.42 (ArC), 137.56 (ArC), 132.32
ArC), 130.15 (2ArCH), 129.35 (2ArCH), 128.20 (2ArCH),
C{ H } NMR (101 MHz, CD Cl , δ): 149.39 (ArC), 143.13
2 2
(TzCH), 142.26 (ArC), 140.23 (ArC), 134.07 (ArC), 133.65
(ArCH), 130.54 (ArCH), 129.64 (2ArCH), 128.65 (2ArCH),
1
27.38 (2ArCH), 52.42 (CH
TOF) m/z: [M + H]+ Calc. for C15
51.1295.
4'-((1H-Tetrazol-1-yl)methyl)-2-biphenylyl)ethan-1-one (2e)
2
), 21.37 (CH
3
); HRMS (ESI-
H
15
N
4
: 251.1297, found
123.04 (ArCH), 122.44 (ArCH), 52.24 (CH
2
); HRMS (ESI-
+
2
TOF) m/z: [M + H] Calc. for C14
282.0980.
12 5 2
H N O : 282.0991, Found
(
The crude product was recrystallized with DCM:PE (1:1) to
afford 2e (white solid, 101.3 mg, 87.0 % yield).
((3'-Chloro-4-biphenylyl)methyl)-1H-tetrazole
(2i)
3-
Chlorophenylboronic acid (72.0 mg, 460.1 μmol) and 1 (100
This article is protected by copyright. All rights reserved.